Antihypertensive agents: Mechanisms of action, safety profiles, and current uses in children

Current Therapeutic Research - Clinical and Experimental

Volumn 62, Issue 4, 2001, Pages 298-313

  Blowey, Douglas L ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Antihypertensives; Children; Hypertension; Mechanism of action

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; CAPTOPRIL; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; FOSINOPRIL; IRBESARTAN; ISRADIPINE; LABETALOL; LISINOPRIL; LOSARTAN; MOEXIPRIL; NICARDIPINE; NIFEDIPINE; NITRENDIPINE; PERINDOPRIL; PHENYLALKYLAMINE; QUINAPRIL; RAMIPRIL; TELMISARTAN; TRANDOLAPRIL; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; COUGHING; DRUG EFFICACY; DRUG ELIMINATION; DRUG INFORMATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG USE; EDEMA; FATIGUE; HEADACHE; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY DISEASE; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TERATOGENESIS; VERTIGO;

EID: 0035013046     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(01)80014-X     Document Type: Conference Paper

References (82)

1. Update on the 1987 task force report on high blood pressure in children and adolescents: A working group report from the national high blood pressure education program
2. Childhood risk factors for high adult blood pressure: The Muscatine study
3. Identification and management of juvenile hypertension
4. Childhood hypertension: Etiology, diagnosis, and treatment
5. Hypertension in childhood
6. Systemic hypertension in children and adolescents
7. Hypertensive encephalopathy in childhood. Diagnostic problems
8. Central nervous system involvement in severe arterial hypertension of childhood
9. Prevalence of "significant" hypertension in junior high school-aged children: The children and adolescent blood pressure program
10. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
11. Systemic hypertension in infants with bronchopulmonary dysplasia
12. Clinical characteristics of hypertension in burned children
13. Traction-induced hypertension in children
14. Blood pressure in obese adolescents: Effect of weight loss
15. Pharmacogenetics in pediatrics
16. Angiotensin-converting enzyme inhibitor fetopathy
17. Effects of the ACE inhibitor, enalapril, in children age 6-16 years with hypertension
18. Multicenter study of enalapril pharmacokinetics in hypertensive children and infants
19. Relative bioavailability of an enalapril suspension for oral administration to children compared to VASOTEC™ tablets
20. Efficacy and safety of captopril in the treatment of severe childhood hypertension: Report of the international collaborative study group
21. Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis
22. Indications and effects of captopril therapy in childhood
23. Treatment of renal hypertension in children by captopril
24. Long-term treatment with captopril in paediatric patients with severe hypertension and chronic renal failure
25. Antihypertensive drug therapy with captopril in children and adolescents
26. Long term therapy by captopril in children with renal hypertension
27. Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease
28. Renal failure in sick hypertensive premature infants receiving captopril therapy
29. Captopril. Long-term treatment of hypertension in a pre-term infant and in older children
30. Angiotensin converting enzyme inhibitor treatment of hypertension in infancy and childhood
31. Angiotensin receptors: What is new?
32. How they begin and how they end: Classic and new theories of the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT
33. Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174 [clinical conference]
34. Side effects of verapamil in infants
35. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia
36. Dosage of nifedipine in hypertensive crises of infants and children
37. Sublingual nifedipine in acute severe hypertension
38. Nifedipine in hypertensive emergencies of children
39. Treatment of hypertensive crises in children with nifedipine
40. Effect of sublingual or oral nifedipine in the treatment of hypertension
41. Nifedipine in hypertensive crises of infants and children
42. Experience with sublingual nifedipine in paediatric hypertensive emergencies
43. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension
44. Intravenous nicardipine in hypertensive children
45. Nicardipine for hypertensive emergencies in children with renal disease
46. Antihypertensive effect and pharmacokinetics of nitrendipine in children
47. A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension
48. Isradipine therapy in hypertensive pediatric patients
49. Initial experience with isradipine for the treatment of hypertension in children
50. Efficacy of amlodipine in pediatric bone marrow transplant patients
51. Efficacy of amlodipine in pediatric patients with hypertension
52. Amlodipine once-daily in systemic hypertension
53. A randomized prospective crossover trial of amlodipine in pediatric hypertension
54. Propranolol versus chlorthalidone - A prospective therapeutic trial in children with chronic hypertension
55. Effectiveness of centrally acting drugs and diuretics in adolescent hypertension
56. Pharmacogenetics in pediatrics. Implications for practice
57. Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood
58. Propranolol as an antihypertensive agent in children
59. Treatment of high-renin hypertension with propranolol in children after renal transplantation
60. Propranolol versus chlorthalidone - A prospective therapeutic trial in children with chronic hypertension
61. Postoperative hypertension after repair of coarctation of aorta in children: Protective effect of propranolol?
62. Plasma propranolol levels in adults with observations in four children
63. Kinetic and clinical observations in cyanotic children on propranolol therapy
64. The pharmacodynamic effectiveness of metoprolol in adolescent hypertension
65. Intravenously administered labetalol for treatment of hypertension in children
66. Esmolol for the management of pediatric hypertension after cardiac operations
67. Pharmacodynamics and pharmacokinetics of esmolol, a short-acting β-blocking agent, in children
68. Pharmacokinetics of esmolol in children
69. Guanabenz for adolescent hypertension
70. Dynamic exercise response in hypertensive adolescents on clonidine therapy: Clonidine therapy in adolescent hypertension
71. Intravenous clonidine in severe childhood hypertension
72. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis
73. Safety of intravenous diazoxide in children with severe hypertension
74. Dose-response relation of diazoxide in children with hypertension
75. Intravenous diazoxide in acute poststreptococcal glomerulonephritis
76. Severe hypertension in children with renal disease: Treatment with minoxidil
77. Management of severe childhood hypertension with minoxidil: A controlled clinical study
78. Minoxidil for control of acute blood pressure elevation in chronically hypertensive children
79. Minoxidil therapy in children with severe hypertension
80. Clinical response of hypertensive children to long-term minoxidil therapy